Physician
Ophthalmology
James Y. Massey, MD is an expert in the field of Ophthalmology. He attended University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83 in research and 35 in primary care medicine He has 1 awards "CMS Meaningful Use Stage 1 Certification". He accepts Medicare.
Schools
Louisiana State Univ School Of Medicine In New Orleans
University of Arkansas For Medical Sciences
University Of Alabama
University Of ArkansasPharmacology
Procedures Preformed
- Eye Examination
- Eye Procedure
- Eyelid Surgery
- Glaucoma Treatment
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Blindness
- Cataract
- Chorioretinal Scars
- View All
Doctors Specialties
- Family Medicine
- Ophthalmology
Accepted Insurances
- Advantage
- Choice
- American Enterprise Group
- Anthem Blue Cross Blue Shield HMO
- Blue Advantage HMO
- Blue Advantage PPO
- Blue Traditional HMO
- Blue Alliance Network
- Blue Advantage
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Commercial Insurance Company
- CoreSource
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Qualchoice PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Arkansas for Medical Sciences
-
Louisiana State University School of Medicine in New Orleans
Drug Facts
NPI NUMBER |
|
1104814656 |
NPPES Provider LastName |
|
MASSEY |
NPPES Provider FirstName |
|
JAMES |
NPPES Provider ZIPCode |
|
725429468 |
NPPES Provider State |
|
AR |
Specialty Description |
|
Ophthalmology |
Total Claim Count |
|
293.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1104814656 |
Last Name Of The Provider |
MASSEY |
First Name Of The Provider |
JAMES |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog